Chemical Structure : Tuvusertib
CAS No.: 1613200-51-3
货号: PC-21858Not For Human Use, Lab Use Only.
Tuvusertib (M1774) is a potent, selective, orally bioavailable ATR protein kinase inhibitor, shows anticancer activity against cance cell with expression the ATR inhibition sensitizing mixed lineage leukemia fusion protein.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1580 | In stock | |
10 mg | ¥2480 | In stock | |
25 mg | ¥3980 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tuvusertib (M1774) is a potent, selective, orally bioavailable ATR protein kinase inhibitor, shows anticancer activity against cance cell with expression the ATR inhibition sensitizing mixed lineage leukemia fusion protein.
Tuvusertib (M1774) shows antitumor activity as monotherapy in preclinical models with DDR pathway gene mutations, including an ATM mut nonsmall-cell lung cancer (NSCLC) xenograft model and an ARID1A mut gastric cancer xenograft model.
Tuvusertib (M1774) also shows antitumor activity as monotherapy and in combination with the PARP inhibitor niraparib in xenograft models of BRCA mut high-grade serous ovarian cancer.
分子量 | 370.32 | |
分子式 | C16H12F2N8O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-Amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
1. Timothy A. Yap, et al. Journal of Clinical Oncology
Volume 39, Number 15_suppl. May 28, 2021
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright